Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-17-002034
Filing Date
2017-08-10
Accepted
2017-08-10 17:12:26
Documents
1
Period of Report
2017-08-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT schutz_f4.html 4  
1 OWNERSHIP DOCUMENT schutz_f4.xml 4 3126
  Complete submission text file 0001683168-17-002034.txt   4555
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address
Schutz James J (Reporting) CIK: 0001367079 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33216 | Film No.: 171022251

Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations